72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
73.11.Z - Advertising agencies activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,2 | 0,2 | 246,4 |
EBITDA | 96,1 | |||
Short time liabilities | 0 | |||
Income tax | 0 | 0 | 0 | -∞ |
Equity capital | -0 | -0,2 | 0 | 119,3 |
Operating profit (EBIT) | 96,1 | |||
Assets | 1,7 | 1,1 | 0,6 | -44,7 |
Net profit (loss) | -0 | -0,2 | 0,2 | 238,9 |
Cash | 0 | |||
Liabilities and provisions for liabilities | 1,7 | 1,3 | 0,6 | -54,8 |
Net income from sale | 0 | |||
Working assets | 0,5 | 0,2 | 0,6 | 200,8 |
Basic operational activity income | 2 | 0,3 | 2,4 | 868,7 |
Depreciation | 0 | |||
% | % | % | p.p. | |
Profitability of capital | 618,4 | 621,1 | ||
Equity capital to total assets | -1,5 | -15,7 | 5,5 | 21,2 |
Gross profit margin | -2,4 | -60,2 | 9,1 | 69,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | |||
Net dept to EBITDA | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane